Immutep competitors

View the competitive landscape for Immutep, featuring companies like Novartis, Bristol Myers Squibb, and Incyte. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Company icon
Immutep

Biotechnology company developing LAG-3 immunotherapies

immutep.com

List of Immutep competitors

  • Company icon

    Novartis

    Multidivisional healthcare company researching immune checkpoint inhibitors for oncology

    novartis.com
  • Company icon

    Bristol Myers Squibb

    Global pharmaceutical company producing first-to-market LAG-3 checkpoint inhibitors

    bms.com
  • Company icon

    Incyte

    Biopharmaceutical company developing immunotherapy inhibitors including LAG-3 clinical assets

    incyte.com
  • Company icon

    Merck

    Biopharmaceutical company developing pembrolizumab combinations with LAG-3 targeted therapies

    merck.com
  • Company icon

    Regeneron

    Biotechnology company advancing clinical programs for LAG-3 antibody treatments

    regeneron.com
  • Company icon

    MacroGenics

    Clinical-stage biopharmaceutical company developing bispecific antibodies including LAG-3 targets

    macrogenics.com
Track Immutep & Its Competitors

Monitor every move they make and get updates delivered to your inbox

Start tracking Immutep

More competitor lists

Browse other recently generated lists to see which companies are trending right now.